Filing Details
- Accession Number:
- 0000950170-24-064271
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-23 21:36:56
- Reporting Period:
- 2024-05-21
- Accepted Time:
- 2024-05-23 21:36:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1157601 | Madrigal Pharmaceuticals Inc. | MDGL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1876996 | E. Robert Waltermire | C/O Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428 | Senior Vp, Chief Pharma Dev. | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-05-21 | 1,036 | $231.34 | 5,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
